from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2740/ephG

LFCtreatmentdescriptionclass of inhibitor

-0.885

Amikacinug/mL Amikacintranslation

0.246

Cap5-10ug/mL Capreomycintranslation

-0.030

Rox10-50 ug/mL Roxithromycintranslation

-0.684

SM2-5 ug/mL Streptomycintranslation

-0.945

Tet5-10 ug/mL Tetracyclinetranslation

0.990

Rif0.2-5ug/mL Rifampicintranscription

-0.480

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.020

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.170

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.582

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.462

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.549

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.902

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.021

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.352

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.118

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.055

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.412

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.274

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.749

KCN5-20 ug/mL Potassium cyaniderespiration

0.098

NaN30.2-2 mM Sodium aziderespiration

-0.255

Nigericin50 uM Nigericinrespiration

0.317

TRC10-150 ug/mL Triclosanrespiration

-0.850

TRZ10-25 ug/mL Thioridazinerespiration

-2.517

Valinomycin0.5-10 uM Valinomycinrespiration

-1.201

ZnSO42 mM ZnSO4respiration

-0.294

menadione6-10 ug/mL Menadionerespiration

-0.138

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.714

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.349

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.680

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.972

NRP_1Non-replicating persistence stage 1dosRassociated

-0.036

Amp0.2mg/mL AmpicillincellWall

-0.658

Cephalexin20-100 ug/mL CephalexincellWall

-0.797

Cerulenin0.32-5 ug/mL CerulenincellWall

1.064

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.519

EMB10-20 ug/mL EthambutolcellWall

-0.101

Eta12-40 ug/mL EthionamidecellWall

-0.743

INH0.2-0.4 ug/mL IsoniazidcellWall

0.243

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.835

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.899

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.217

BZA0.12 mg/mL BenzamidearomaticAmides

0.450

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.117

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.497

H2O24 mM hydrogen peroxideDNAdamaging

-0.033

Levo10 ug/mL LevofloxacinDNAdamaging

0.238

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.915

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.119

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.063

UVUV-irradiationDNAdamaging

-0.874

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.371

Antimycin12.5-50 ug/mL Antimycin A?

-0.384

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.030

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.475

PA8240.2-2 ug/mL PA-824?

-1.068

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.867

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.817

Verapamil50 uM Verapamil?

-0.091

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.243

methoxatin10-20 ug/mL Methoxatin?